FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109879423> ?p ?o ?g. }

• W2109879423 endingPage "4454" @default.
• W2109879423 startingPage "4444" @default.
• W2109879423 abstract "Purpose: In 1999, investigators reported promising results of a phase II study of thalidomide in patients with resistant multiple myeloma (MM). Since then, various trials of thalidomide alone and in combination with other agents have been tested in patients with resistant and, more recently, untreated MM. In addition, preliminary results of phase I studies of the immunomodulatory derivatives (IMiDs) of thalidomide have been recently reported. Design: We reviewed and report the results of clinical trials of thalidomide and the IMiDs, as well as the pharmacology, mechanism of action, and toxicity of these agents. Results: Thalidomide has demonstrated significant activity in both resistant and previously untreated multiple myeloma. Combination therapy with dexamethasone increases response rate, even in patients previously resistant to both drugs given as single agents. More recent studies of thalidomide with dexamethasone in previously untreated patients are highly encouraging. The addition of chemotherapy to thalidomide and dexamethasone may further increase response rates, but its effect on patient survival has not been clarified. Preliminary results of trials of IMiD-3 indicate that this agent is active in resistant myeloma and has a toxicity profile different from that of thalidomide. Conclusion: Many studies have confirmed the activity of thalidomide in MM, as well as an improved response with dexamethasone. Newer thalidomide derivatives with reduced toxicity (neuropathy, teratogenicity) are also promising. Thalidomide with dexamethasone may now represent the treatment of choice for previously untreated patients. Further studies with these and other novel agents early in the course of myeloma may improve complete remission rates and frequency of long-term control." @default.
• W2109879423 created "2016-06-24" @default.
• W2109879423 creator A5033573338 @default.
• W2109879423 creator A5055929208 @default.
• W2109879423 creator A5059125706 @default.
• W2109879423 date "2003-12-01" @default.
• W2109879423 modified "2023-10-16" @default.
• W2109879423 title "Treatment of Plasma Cell Dyscrasias With Thalidomide and Its Derivatives" @default.
• W2109879423 cites W1528751727 @default.
• W2109879423 cites W1779162675 @default.
• W2109879423 cites W1798928306 @default.
• W2109879423 cites W1924027236 @default.
• W2109879423 cites W1966156828 @default.
• W2109879423 cites W1967253857 @default.
• W2109879423 cites W1970583650 @default.
• W2109879423 cites W1972264308 @default.
• W2109879423 cites W1976709963 @default.
• W2109879423 cites W1980159411 @default.
• W2109879423 cites W1984207121 @default.
• W2109879423 cites W1985147506 @default.
• W2109879423 cites W1985658104 @default.
• W2109879423 cites W1988605844 @default.
• W2109879423 cites W1991661459 @default.
• W2109879423 cites W1994394328 @default.
• W2109879423 cites W1999565376 @default.
• W2109879423 cites W2005850131 @default.
• W2109879423 cites W2018491765 @default.
• W2109879423 cites W2032156408 @default.
• W2109879423 cites W2032411201 @default.
• W2109879423 cites W2034031119 @default.
• W2109879423 cites W2036343984 @default.
• W2109879423 cites W2039166615 @default.
• W2109879423 cites W2042816067 @default.
• W2109879423 cites W2048141239 @default.
• W2109879423 cites W2062851970 @default.
• W2109879423 cites W2066936999 @default.
• W2109879423 cites W2067161281 @default.
• W2109879423 cites W2078945448 @default.
• W2109879423 cites W2088834215 @default.
• W2109879423 cites W2088916841 @default.
• W2109879423 cites W2091364576 @default.
• W2109879423 cites W2096746091 @default.
• W2109879423 cites W2102591890 @default.
• W2109879423 cites W2103660186 @default.
• W2109879423 cites W2109694492 @default.
• W2109879423 cites W2111454841 @default.
• W2109879423 cites W2113101033 @default.
• W2109879423 cites W2118006412 @default.
• W2109879423 cites W2119810076 @default.
• W2109879423 cites W2120161314 @default.
• W2109879423 cites W2122284431 @default.
• W2109879423 cites W2125559109 @default.
• W2109879423 cites W2127206962 @default.
• W2109879423 cites W2132073540 @default.
• W2109879423 cites W2132242107 @default.
• W2109879423 cites W2133776402 @default.
• W2109879423 cites W2133986577 @default.
• W2109879423 cites W2136226957 @default.
• W2109879423 cites W2137984904 @default.
• W2109879423 cites W2142149038 @default.
• W2109879423 cites W2142241855 @default.
• W2109879423 cites W2144531125 @default.
• W2109879423 cites W2167736322 @default.
• W2109879423 cites W2171194005 @default.
• W2109879423 cites W2316160054 @default.
• W2109879423 cites W3024582074 @default.
• W2109879423 cites W3145716452 @default.
• W2109879423 cites W4240558622 @default.
• W2109879423 cites W4241442958 @default.
• W2109879423 cites W4254235859 @default.
• W2109879423 cites W4255978160 @default.
• W2109879423 cites W4313376856 @default.
• W2109879423 doi "https://doi.org/10.1200/jco.2003.07.200" @default.
• W2109879423 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14645435" @default.
• W2109879423 hasPublicationYear "2003" @default.
• W2109879423 type Work @default.
• W2109879423 sameAs 2109879423 @default.
• W2109879423 citedByCount "115" @default.
• W2109879423 countsByYear W21098794232012 @default.
• W2109879423 countsByYear W21098794232013 @default.
• W2109879423 countsByYear W21098794232014 @default.
• W2109879423 countsByYear W21098794232015 @default.
• W2109879423 countsByYear W21098794232017 @default.
• W2109879423 countsByYear W21098794232019 @default.
• W2109879423 countsByYear W21098794232021 @default.
• W2109879423 countsByYear W21098794232023 @default.
• W2109879423 crossrefType "journal-article" @default.
• W2109879423 hasAuthorship W2109879423A5033573338 @default.
• W2109879423 hasAuthorship W2109879423A5055929208 @default.
• W2109879423 hasAuthorship W2109879423A5059125706 @default.
• W2109879423 hasConcept C126322002 @default.
• W2109879423 hasConcept C143998085 @default.
• W2109879423 hasConcept C2776364478 @default.
• W2109879423 hasConcept C2776694085 @default.
• W2109879423 hasConcept C2779609412 @default.
• W2109879423 hasConcept C2780401358 @default.
• W2109879423 hasConcept C29730261 @default.
• W2109879423 hasConcept C535046627 @default.

• next